These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35932692)

  • 1. BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A.
    Guo P; Zu S; Han S; Yu W; Xue G; Lu X; Lin H; Zhao X; Lu H; Hua C; Wan X; Ru L; Guo Z; Ge H; Lv K; Zhang G; Deng W; Luo C; Guo W
    Redox Biol; 2022 Sep; 55():102418. PubMed ID: 35932692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
    Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
    Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
    Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BPTF cooperates with p50 NF-κB to promote COX-2 expression and tumor cell growth in lung cancer.
    Dai M; Hu S; Liu CF; Jiang L; Yu W; Li ZL; Guo W; Tang R; Dong CY; Wu TH; Deng WG
    Am J Transl Res; 2019; 11(12):7398-7409. PubMed ID: 31934287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
    Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
    Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular states.
    Felipe I; Martínez-de-Villarreal J; Patel K; Martínez-Torrecuadrada J; Grossmann LD; Roncador G; Cubells M; Farrell A; Kendsersky N; Sabroso-Lasa S; Sancho-Temiño L; Torres K; Martinez D; Perez JM; García F; Pogoriler J; Moreno L; Maris JM; Real FX
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A.
    Ma Y; Wang R; Lu H; Li X; Zhang G; Fu F; Cao L; Zhan S; Wang Z; Deng Z; Shi T; Zhang X; Chen W
    J Cancer; 2020; 11(8):2158-2170. PubMed ID: 32127943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
    Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
    J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis.
    Richart L; Carrillo-de Santa Pau E; Río-Machín A; de Andrés MP; Cigudosa JC; Lobo VJS; Real FX
    Nat Commun; 2016 Jan; 7():10153. PubMed ID: 26729287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.
    Bezrookove V; Khan IA; Nosrati M; Miller JR; McAllister S; Dar AA; Kashani-Sabet M
    Front Oncol; 2022; 12():1011173. PubMed ID: 36530982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ_0007142 Facilitates Colorectal Cancer Progression by Modulating CDC25A Expression via miR-122-5p.
    Yin W; Xu J; Li C; Dai X; Wu T; Wen J
    Onco Targets Ther; 2020; 13():3689-3701. PubMed ID: 32431519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
    Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
    J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
    Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
    Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cdc25A is necessary but not sufficient for optimal c-myc-induced apoptosis and cell proliferation of vascular smooth muscle cells.
    Macdonald K; Bennett MR
    Circ Res; 1999 Apr; 84(7):820-30. PubMed ID: 10205150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
    Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
    Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of new small molecule inhibitors of the BPTF bromodomain.
    Liang X; Cao Y; Duan Z; Wang M; Zhang N; Ding Y; Luo C; Lu N; Chen S
    Bioorg Chem; 2023 May; 134():106453. PubMed ID: 36898211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition.
    Zahid H; Buchholz CR; Singh M; Ciccone MF; Chan A; Nithianantham S; Shi K; Aihara H; Fischer M; Schönbrunn E; Dos Santos CO; Landry JW; Pomerantz WCK
    J Med Chem; 2021 Sep; 64(18):13902-13917. PubMed ID: 34515477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.